Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development

Abstract Despite the advances in intensive chemotherapy regimens and targeted therapies, overall survival (OS) of acute myeloid leukemia (AML) remains unfavorable due to inevitable chemotherapy resistance and high relapse rate, which mainly caused by the persistence existence of leukemia stem cells...

Full description

Bibliographic Details
Main Authors: Yiyi Yao, Fenglin Li, Jiansong Huang, Jie Jin, Huafeng Wang
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Experimental Hematology & Oncology
Subjects:
Online Access:https://doi.org/10.1186/s40164-021-00233-2
_version_ 1830510736650010624
author Yiyi Yao
Fenglin Li
Jiansong Huang
Jie Jin
Huafeng Wang
author_facet Yiyi Yao
Fenglin Li
Jiansong Huang
Jie Jin
Huafeng Wang
author_sort Yiyi Yao
collection DOAJ
description Abstract Despite the advances in intensive chemotherapy regimens and targeted therapies, overall survival (OS) of acute myeloid leukemia (AML) remains unfavorable due to inevitable chemotherapy resistance and high relapse rate, which mainly caused by the persistence existence of leukemia stem cells (LSCs). Bone marrow microenvironment (BMM), the home of hematopoiesis, has been considered to play a crucial role in both hematopoiesis and leukemogenesis. When interrupted by the AML cells, a malignant BMM formed and thus provided a refuge for LSCs and protecting them from the cytotoxic effects of chemotherapy. In this review, we summarized the alterations in the bidirectional interplay between hematopoietic cells and BMM in the normal/AML hematopoietic environment, and pointed out the key role of these alterations in pathogenesis and chemotherapy resistance of AML. Finally, we focused on the current potential BMM-targeted strategies together with future prospects and challenges. Accordingly, while further research is necessary to elucidate the underlying mechanisms behind LSC–BMM interaction, targeting the interaction is perceived as a potential therapeutic strategy to eradicate LSCs and ultimately improve the outcome of AML.
first_indexed 2024-12-22T01:58:01Z
format Article
id doaj.art-45531155973a43bebed7a1edd8879d23
institution Directory Open Access Journal
issn 2162-3619
language English
last_indexed 2024-12-22T01:58:01Z
publishDate 2021-07-01
publisher BMC
record_format Article
series Experimental Hematology & Oncology
spelling doaj.art-45531155973a43bebed7a1edd8879d232022-12-21T18:42:43ZengBMCExperimental Hematology & Oncology2162-36192021-07-0110111910.1186/s40164-021-00233-2Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia developmentYiyi Yao0Fenglin Li1Jiansong Huang2Jie Jin3Huafeng Wang4Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityDepartment of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityDepartment of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityDepartment of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityDepartment of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityAbstract Despite the advances in intensive chemotherapy regimens and targeted therapies, overall survival (OS) of acute myeloid leukemia (AML) remains unfavorable due to inevitable chemotherapy resistance and high relapse rate, which mainly caused by the persistence existence of leukemia stem cells (LSCs). Bone marrow microenvironment (BMM), the home of hematopoiesis, has been considered to play a crucial role in both hematopoiesis and leukemogenesis. When interrupted by the AML cells, a malignant BMM formed and thus provided a refuge for LSCs and protecting them from the cytotoxic effects of chemotherapy. In this review, we summarized the alterations in the bidirectional interplay between hematopoietic cells and BMM in the normal/AML hematopoietic environment, and pointed out the key role of these alterations in pathogenesis and chemotherapy resistance of AML. Finally, we focused on the current potential BMM-targeted strategies together with future prospects and challenges. Accordingly, while further research is necessary to elucidate the underlying mechanisms behind LSC–BMM interaction, targeting the interaction is perceived as a potential therapeutic strategy to eradicate LSCs and ultimately improve the outcome of AML.https://doi.org/10.1186/s40164-021-00233-2Acute myeloid leukemiaBone marrow microenvironmentLeukemia stem cellInteractionEnvironment-mediated drug resistance
spellingShingle Yiyi Yao
Fenglin Li
Jiansong Huang
Jie Jin
Huafeng Wang
Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
Experimental Hematology & Oncology
Acute myeloid leukemia
Bone marrow microenvironment
Leukemia stem cell
Interaction
Environment-mediated drug resistance
title Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
title_full Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
title_fullStr Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
title_full_unstemmed Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
title_short Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
title_sort leukemia stem cell bone marrow microenvironment interplay in acute myeloid leukemia development
topic Acute myeloid leukemia
Bone marrow microenvironment
Leukemia stem cell
Interaction
Environment-mediated drug resistance
url https://doi.org/10.1186/s40164-021-00233-2
work_keys_str_mv AT yiyiyao leukemiastemcellbonemarrowmicroenvironmentinterplayinacutemyeloidleukemiadevelopment
AT fenglinli leukemiastemcellbonemarrowmicroenvironmentinterplayinacutemyeloidleukemiadevelopment
AT jiansonghuang leukemiastemcellbonemarrowmicroenvironmentinterplayinacutemyeloidleukemiadevelopment
AT jiejin leukemiastemcellbonemarrowmicroenvironmentinterplayinacutemyeloidleukemiadevelopment
AT huafengwang leukemiastemcellbonemarrowmicroenvironmentinterplayinacutemyeloidleukemiadevelopment